Rapport d’analyse de la taille, de la part et des tendances du marché mondial des injecteurs de produits de contraste – Aperçu et prévisions de l’industrie jusqu’en 2031

Marché des injecteurs de produits de contraste

Le nombre croissant de compétences en recherche et développement apporte des innovations dans les systèmes d'injection de produits de contraste. Le nombre croissant de scientifiques et de chercheurs menant leurs études de recherche portant sur l'analyse des tissus a élargi le champ de croissance du marché. Les « systèmes d'injection » dominent le segment de produits du marché des injecteurs de produits de contraste en raison du développement et du lancement croissants de nouveaux vaccins, d'un pipeline robuste et de l'augmentation du revenu personnel disponible.                               

Taille du marché des injecteurs de produits de contraste

La taille du marché mondial des injecteurs de produits de contraste a été évaluée à 1,63 milliard USD en 2023 et devrait atteindre 2,95 milliards USD d'ici 2031, avec un TCAC de 7,75 % au cours de la période de prévision de 2024 à 2031.

Portée du rapport et segmentation du marché       

Définition du marché des injecteurs de produits de contraste

Contract media injectors are the injectable, injected into the body with an aim to look at a better image of tissues for medical imaging procedures. Also known as power injectors, the contrast media injectors are used for a wide range of therapeutic and diagnostic procedures.   

Contrast Media Injectors Market Dynamics

Drivers

• The rise in the prevalence of diseases

Surging prevalence of chronic and acute diseases and disorders in individuals all around the globe that require early diagnosis and on-time treatment for prevention of complications is one of the major factors responsible for fostering growth in the market value. Rising incidence rate of cancer, physical injury, stroke, heart disease, vascular disease, digestive disorder and many more is directly propelling the market growth rate.    

• Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. According to World Health Organization in 2021, cardiovascular diseases accounted the top position for being responsible for the highest number of deaths globally.

• Government investments on healthcare infrastructure

The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities.

Additionally, surge in the personal disposable income level, increasing demand for minimally invasive surgeries and increasing investment for the development of advanced, governmental support in approving the medical technology, positively affect the market growth rate.

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, regulatory approval of a growing number of contrast agents and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2024 to 2031. Additionally, surging number of strategic collaborations, rising internet penetration rate, increase in the number of public and private diagnostic centers, technological and biotechnological advancements regarding diagnostics and therapeutics in the developing regions and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and increased cost of contrast media injectors, consumables, and accessories are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, rising risks associated with contrast media injectors, lack of skilled medical professionals in the developing and underdeveloped regions and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2024-2031.

This contrast media injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contrast media injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Contrast Media Injectors Market

COVID-19 has significantly and negatively impacted the market. The funding for research and development activities was significantly reduced and cut down. Supply chain disruptions demoted the market demand and supply. There was a huge postponement on the non-essential medical procedures. Significant disruptions experienced by their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns has further worsened the situation. Further, radiology departments have experienced a rapid decline in imaging case volume has forther derail the market growth rate. All of this proved to be a bane for the market during pandemic.

Contrast Media Injectors Market Scope

The contrast media injectors market is segmented on the basis of type, product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Single Head
• Dual-Head
• Syringeless Injectors

Product

• Injector Systems
  • CT Injector Systems
  • MRI Injector Systems
  • Angiography Injector Systems
• Consumables
  • Injector Heads
  • Syringes
  • Tubing
  • Other Consumables and Accessories

Application  

• Radiology
• Interventional Cardiology
• Interventional Radiology

End-user

• Hospitals
• Ambulatory Surgical Centres
• Diagnostics Centres

Contrast Media Injectors Market Regional Analysis

The contrast media injectors market is analysed and market size insights and trends are provided by country, type, product, application and end-user as referenced above.

The countries covered in the contrast media injectors market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the contrast media injectors market because of the strong base of healthcare facilities, rising availability of advanced IT-enabled solutions for data management, and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in government initiatives to promote awareness, rising cases of cancer, orthopedic diseases, epilepsy, and Alzheimer's disease and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The contrast media injectors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for contrast media injectors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the contrast media injectors market. The data is available for historic period 2010-2020.

Contrast Media Injectors Market Share

Le paysage concurrentiel du marché des injecteurs de produits de contraste fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination de l'application. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des injecteurs de produits de contraste.

Les leaders du marché des injecteurs de produits de contraste opérant sur le marché sont :

• Boehringer Ingelheim International GmbH (Allemagne)
• Sanofi (France)
• Novartis SA (Suisse)
• Merck Sharp & Dohme Corp. (Allemagne)
• Bracco Imaging SpA (Italie)
• Guerbet (France)
• Medtron AG (Allemagne)
• Bayer AG (Allemagne)
• ulrich medical (Allemagne)
• SOCIÉTÉ GÉNÉRALE D'ÉLECTRICITÉ (ÉTATS-UNIS)
• IMAGERIE VIVID (États-Unis)
• Sino Medical Sciences Technology Inc. (Chine)
• AngioDynamics (États-Unis)
• APOLLO RT Co. Ltd (États-Unis)
• Nemoto (Japon)
• Messe Düsseldorf GmbH (Allemagne)
• Hilin Life Products, Inc. (États-Unis)
• Jodas Expoim (Inde)
• Lantheus Medical Imaging, Inc (États-Unis)
• Magnus Health (États-Unis)
• TAEJOON PHARM (Corée du Sud)
• Spago Nanomedical AB (Suède)

Dernier développement sur le marché des injecteurs de produits de contraste

• En décembre 2021, Guerbet et Bracco Imaging ont annoncé la signature d'une collaboration mondiale pour le Gadopiclenol, un agent de contraste d'imagerie par résonance magnétique (IRM) de nouvelle génération
• En décembre 2021, Qaelum NV a annoncé un partenariat stratégique avec ulrich GmbH & Co. KG à Ulm pour combiner sa solution avancée de gestion des contrastes avec les injecteurs de produits de contraste d'ulrich medical, afin de répondre aux besoins des hôpitaux et des réseaux d'imagerie

SKU-1598